Noteworthy

Mar 16, 2018
Pharmaceutical Executive
Outcomes-based contracting could be a potential game-changer in linking drug cost with value, boosting healthcare efficiency, and ensuring that appropriate patients benefit from innovative medicines. But several complex challenges remain in the bid to make this model a mainstay.
Mar 07, 2018
Pharmaceutical Executive
Markus Warmuth, CEO of cancer genomics company H3 Biomedicine, speaks with Pharm Exec about being part of a new wave of biotech business leaders, who let the science chart the course.
Mar 07, 2018
Pharmaceutical Executive
How one pharma vet helped create the first industry-wide training standards for aspiring medical affairs professionals. 
Mar 06, 2018
Pharmaceutical Executive
Drawing from implementation lessons and successes in other industries, possible strategy shifts to pharma’s pricing playbook are explored.
Mar 01, 2018
Jin Zhang outlines four key areas that impacted Chinese pharma in 2017 and looks at how their effects will shape the industry in the years ahead.
Feb 20, 2018
Scott Beauchamp discussed the future of analytics in the life sciences industry—and look at how peers in other industries have reaped the benefits of being early movers.
Feb 15, 2018
Pharmaceutical Executive
This article examines the key ways the new tax bill will impact the pharmaceutical industry.
Feb 12, 2018
Pharmaceutical Executive
The biotech sector has managed to elude the negative perceptions saddling traditional pharma these days. We examine the reasons why.
Feb 12, 2018
Pharmaceutical Executive
Lieutenant General (Ret) Rick Lynch, US Army, and Bob Jansen, CEO of Zensights, discuss the military-industry effort to instill the principles of adaptive leadership into today’s pharma leader.
Feb 12, 2018
Pharmaceutical Executive
Whether the pharma industry is navigating calm or choppy waters, it should be smarter and more assertive in telling its story to its stakeholders—most importantly, patients and the wider public.
native1_300x100
lorem ipsum